This metabolic profile aligns with a role of SLC39A1-KO in mitochondrial function, possibly through zinc-dependent inhibition of mitochondrial aconitase, as previously reported for prostate cancer cells (Singh et al, 2006). The gene discussed is ACO2; the disease is prostate cancer.